Category Archives: TRIPS&IP rights

Ingredients for WHO roadmap on access to medicines at civil society side event

Source: Intellectual Property Watch | May 25, 2018 On the side of this week’s World Health Assembly and hours before the Assembly agreed on preparing a roadmap on access to medicines, two civil society groups held an event on the … Continue reading

Posted in Access to Medecines, Cancer, IPR, TRIPS, WHO | Leave a comment

NAFTA and International Public Health: An interfaith call for access to medicines

Source: United States Conference of Catholics Bishops Recognizing the inherent dignity of the human person, our faith traditions call us to care for the sick and respond to the needs of the poor in our societies. Trade agreements can have enormous … Continue reading

Posted in Access to Medecines, NAFTA, TRIPS, TRIPS&IP rights | Leave a comment

WHA agrees on drafting of roadmap for access to medicines and vaccines; US blasts compulsory licences

Source: Intellectual Property Watch|25th May 2018 The World Health Assembly yesterday agreed on a roadmap to be designed by the World Health Organization in consultation with member states to facilitate access to medicines and vaccines, including actions and activities for … Continue reading

Posted in Access to Medecines, Compulsory Licensing, Vaccines | Leave a comment

US faith-based groups call for no TRIPS-plus in NAFTA

Top leadership from multiple major faith denominations strongly reaffirmed their traditions’ recognition of the human right to health, and insisted that trade agreements including a renegotiated NAFTA should not include terms that extend medicine monopolies. The statement, found here: http://www.usccb.org/issues-and-action/human-life-and-dignity/global-issues/trade/upload/NAFTA-and-International-Public-Health-An-Interfaith-Call-for-Access-to-Medicines.pdfContinue reading

Posted in NAFTA, TRIPS, TRIPS plus, Uncategorized | Leave a comment

Monsanto Can’t Have Patent on Bt Cotton in India, Court Says

Source: Bloomberg | April 11, 2018 Monsanto Co., the world’s largest seed company, can’t own a patent over genetically modified cotton seeds in India, a court ruled on Wednesday. The Delhi High Court verdict said that certain items such as … Continue reading

Posted in Court Cases, Patent, Patents | Leave a comment

Scottish government urged to make breast cancer drug available to Scots

Source: The National | April 24, 2018 A WOMAN forced to choose between accessing a breast cancer drug and moving back to be near family in Scotland has urged Holyrood (Scottish government) to help patients. Dunise MacIver was working in London when doctors … Continue reading

Posted in Access to Medicins, Cancer, Compulsory Licensing, Diseases/Therapies, Drug prices | Leave a comment

U.S. wants patent form recall

Source: The Hindu | April 15, 2018 Submission on interpretation of a domestic patent law raises eyebrows The United States Patent and Trademark Office (USPTO) has demanded the elimination of ‘Form 27’— a statutory requirement unique to India’s patent law … Continue reading

Posted in Indian Patent Law, Indian Patent Office, IP Rights, IPR, Patent Enforcement, Patent infringement, US pressure on India | Leave a comment